M&A Deal Summary

Alliance Pharma Acquires Biogix

On December 29, 2020, Alliance Pharma acquired medical products company Biogix for 110M USD

Acquisition Highlights
  • This is Alliance Pharma’s 2nd transaction in the Medical Products sector.
  • This is Alliance Pharma’s largest (disclosed) transaction.
  • This is Alliance Pharma’s 1st transaction in the United States.
  • This is Alliance Pharma’s 1st transaction in California.

M&A Deal Summary
Date 2020-12-29
Target Biogix
Sector Medical Products
Buyer(s) Alliance Pharma
Deal Type Add-on Acquisition
Deal Value 110M USD

Target

Biogix

El Segundo, California, United States
Biogix, Inc. is a science-driven company that develops, tests, manufactures, and distributes innovative products based on an unique platform of bioactive antioxidants. Biogix is based in El Segundo, California.

Search 202,196 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Alliance Pharma

Chippenham, United Kingdom
Category Company
Founded 1996
Sector Life Science
Employees290
Revenue 181M GBP (2023)
DESCRIPTION

Alliance Pharma is a specialty pharmaceutical company. Alliance Pharma was incorporated in 1996 and is based in Chippenham, the United Kingdom.

DEAL STATS #
Overall 2 of 2
Sector (Medical Products) 2 of 2
Type (Add-on Acquisition) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2020) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-12-16 Ferndale Pharmaceuticals - Quinoderm and Ceanel

United Kingdom

Ferndale Pharmaceuticals - Quinoderm and Ceanel is a provider of acne treatment and scalp treatment.

Buy £2M
Mergr

Product

Company

Legal